AD
Recombinant insulin Human(CAS: 11061-68-0)
CAS Number
Related Products
Amino(2-chlorophenyl)acetic acid
CAS Number: 141196-64-7
2-(Octyloxy)ethanol
CAS Number: 27252-75-1
![Sodium 3-({[(1E,4E)-4-({4-[(4-ethoxyphenyl)amino]phenyl}{4-[ethyl(3-sulfonatobenzyl)amino]-2-methylphenyl}methylene)-3-methyl-2,5-cyclohexadien-1-ylidene](ethyl)ammonio}methyl)benzenesulfonate](https://static.chemtradehub.com/structs/610/6104-58-1-ca5a.webp)
Rosiglitazone maleate
CAS Number: 155141-29-0
![5-Amino-1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-6,8-difluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid](https://static.chemtradehub.com/structs/110/110871-86-8-4053.webp)
Lactonic Sophorolipid
CAS Number: 148409-20-5
Iron(III) hexacyanoferrate(II)
CAS Number: 14038-43-8
Ferulic Acid
CAS Number: 1135-24-6
Other Suppliers for Recombinant insulin Human
Basic Information
Molecular Formula
C257H383N65O77S6
Molecular Weight
5808 g/mol
Physical Properties
Water Solubility
Soluble up to 10mg/ml in pH <3 or in the presence of surfactants. Adjusting pH with a volatile acid (such as formic acid) prior to dry down will allow the product to be re-dissolved in water.
Chemical Identifiers
SMILES
CCC(C)C1C(=O)NC2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CC(C)C)CC3=CC=C(C=C3)O)CCC(=O)N)CC(C)C)CCC(=O)O)CC(=O)N)CC4=CC=C(C=C4)O)C(=O)NC(CC(=O)N)C(=O)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CC5=CC=CC=C5)C(=O)NC(CC6=CC=CC=C6)C(=O)NC(CC7=CC=C(C=C7)O)C(=O)NC(C(C)O)C(=O)N8CCCC8C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)O)C(C)C)CC(C)C)CC9=CC=C(C=C9)O)CC(C)C)C)CCC(=O)O)C(C)C)CC(C)C)CC2=CNC=N2)CO)NC(=O)C(CC(C)C)NC(=O)C(CC2=CNC=N2)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC2=CC=CC=C2)N)C(=O)NC(C(=O)NC(C(=O)N1)CO)C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(C)CC)NC(=O)CN
InChIKey
PBGKTOXHQIOBKM-UHFFFAOYSA-N
Database References
MDL Number
MFCD00131380
FAQ
Recombinant insulin human (CAS: 11061-68-0) is subject to strict regulatory guidelines, including GHS classification for hazardous chemicals, REACH regulations for the European market, and FDA and EPA requirements for clinical and commercial use in the U.S. It must undergo rigorous safety and efficacy testing before approval and ongoing compliance with pharmacovigilance standards.
Alternatives to recombinant insulin human (CAS: 11061-68-0) in synthesis include analogs like insulin glargine and lispro, which have modified structures for improved efficacy. Common alternative reagents include different expression systems, such as yeast or insect cells, and other biotechnological approaches for protein production.
The market for recombinant insulin human (CAS: 11061-68-0) is driven by increasing diabetes prevalence and advanced biopharmaceutical technologies. Research trends focus on insulin analogs, long-acting formulations, and personalized medicine. Market trends show steady growth with a focus on reducing side effects and improving patient outcomes.
Waste containing recombinant insulin human (CAS: 11061-68-0) should be collected in appropriate containers and disposed of through professional waste disposal services. Proper incineration or chemical treatment is necessary to ensure safety and meet regulatory requirements. Environmental protection measures, such as minimizing the release of hazardous substances, must also be followed to prevent contamination of water and soil.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Xiao Peng
2771739180@qq.com
Mobile
18013301590
Telephone
025-84699383-8004
Visit Website
https://www.njduly.comAddress
Chuanxinhuai